TARA BARTO to Cystic Fibrosis Transmembrane Conductance Regulator
This is a "connection" page, showing publications TARA BARTO has written about Cystic Fibrosis Transmembrane Conductance Regulator.
Connection Strength
0.204
-
A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation. J Cyst Fibros. 2021 03; 20(2):234-242.
Score: 0.170
-
Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR. J Cyst Fibros. 2018 03; 17(2):228-235.
Score: 0.034